Literature DB >> 27401626

Eosinophilic Endotype of Asthma.

Fernando Aleman1, Hui Fang Lim2, Parameswaran Nair3.   

Abstract

Asthma is a heterogeneous disease that can be classified into different clinical endotypes, depending on the type of airway inflammation, clinical severity, and response to treatment. This article focuses on the eosinophilic endotype of asthma, which is defined by the central role that eosinophils play in the pathophysiology of the condition. It is characterized by elevated sputum and/or blood eosinophils on at least 2 occasions and by a significant response to treatments that suppress eosinophilia. Histopathologic demonstration of eosinophils in the airways provides the most direct diagnosis of eosinophilic asthma; but it is invasive, thus, impractical in clinical practice.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Airway inflammation; Asthma; Endotype; Eosinophil; Sputum

Mesh:

Substances:

Year:  2016        PMID: 27401626     DOI: 10.1016/j.iac.2016.03.006

Source DB:  PubMed          Journal:  Immunol Allergy Clin North Am        ISSN: 0889-8561            Impact factor:   3.479


  20 in total

1.  Efficacy and safety of benralizumab in patients with eosinophilic asthma: a meta-analysis of randomized placebo-controlled trials.

Authors:  Ting Liu; Faping Wang; Geng Wang; Hui Mao
Journal:  Front Med       Date:  2017-10-30       Impact factor: 4.592

2.  Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease.

Authors:  Jeong H Yun; Andrew Lamb; Robert Chase; Dave Singh; Margaret M Parker; Aabida Saferali; Jørgen Vestbo; Ruth Tal-Singer; Peter J Castaldi; Edwin K Silverman; Craig P Hersh
Journal:  J Allergy Clin Immunol       Date:  2018-04-28       Impact factor: 10.793

3.  Assessment of Lung Eosinophils In Situ Using Immunohistological Staining.

Authors:  Christopher D Nazaroff; William E LeSuer; Mia Y Masuda; Grace Pyon; Paige Lacy; Elizabeth A Jacobsen
Journal:  Methods Mol Biol       Date:  2021

4.  IL-3 up-regulates and activates human eosinophil CD32 and αMβ2 integrin causing degranulation.

Authors:  S Esnault; M W Johansson; E A Kelly; L Koenderman; D F Mosher; N N Jarjour
Journal:  Clin Exp Allergy       Date:  2017-01-23       Impact factor: 5.018

Review 5.  Paucigranulocytic asthma: Uncoupling of airway obstruction from inflammation.

Authors:  Omar Tliba; Reynold A Panettieri
Journal:  J Allergy Clin Immunol       Date:  2018-06-19       Impact factor: 10.793

6.  Anti-interleukin 5 Therapy for Eosinophilic Asthma: a Meta-analysis of Randomized Clinical Trials.

Authors:  Fa-Ping Wang; Xiao-Feng Xiong; Ting Liu; Su-Yun Li; De-Yun Cheng; Hui Mao
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

7.  Regulation of Eosinophil and Group 2 Innate Lymphoid Cell Trafficking in Asthma.

Authors:  Marie-Chantal Larose; Anne-Sophie Archambault; Véronique Provost; Michel Laviolette; Nicolas Flamand
Journal:  Front Med (Lausanne)       Date:  2017-08-11

8.  IL-33 Drives Monocyte Recruitment to Lung Interstitium through Chemokine Upregulation.

Authors:  Melissa Y Tjota; Daniel F Camacho; Heth R Turnquist; Anne I Sperling
Journal:  Immunohorizons       Date:  2017-08-15

Review 9.  Reslizumab in the treatment of inadequately controlled asthma in adults and adolescents with elevated blood eosinophils: clinical trial evidence and future prospects.

Authors:  Jorge Máspero
Journal:  Ther Adv Respir Dis       Date:  2017-07-06       Impact factor: 4.031

Review 10.  Asthma Endotypes and an Overview of Targeted Therapy for Asthma.

Authors:  Sarah Svenningsen; Parameswaran Nair
Journal:  Front Med (Lausanne)       Date:  2017-09-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.